AI-enabled Communication to Advance Research Engagement (AI-CARE)
AI-CARE
2 other identifiers
interventional
250
1 country
1
Brief Summary
The objective of AI-CARE is to train researchers and community members to use artificial intelligence (AI) to create plain-language summaries of research studies and to determine whether a co-creation process for developing these summaries improves understanding and relevance of the research, confidence in AI and in institutions, and AI literacy. The hypothesis is that AI-generated research summaries, co-developed with researchers and community partners, will significantly improve confidence in research and institutions, understanding and accessibility of the research, and appropriateness of the summary compared with standard researcher-generated materials, and that the educational and co-creation process will build community members' AI literacy and confidence in using AI, as well as researchers' readiness to use and comfort with using AI for communicating research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2026
CompletedFirst Posted
Study publicly available on registry
August 27, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
Study Completion
Last participant's last visit for all outcomes
September 1, 2028
August 27, 2026
August 1, 2026
2 years
August 24, 2026
August 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Confidence in medical research and researchers - Aim 3
This is the primary outcome measure for both Aim 2 and Aim 3. This outcome measure will be assessed using subscale 1 of the PoRT scale. PoRT is a validated, self-report measure that assesses confidence in medical research and researchers. Subscale 1 contains 9 items, with response options for each item ranging from 1 (strongly disagree) to 5 (strongly agree); thus the subscale ranges from 9 to 45. Higher scores indicate higher confidence.
Immediately following review of research summary, up to 1 hour
Confidence in medical research and researchers - Aim 2
This is the primary outcome measure for both Aim 2 and Aim 3. This outcome measure will be assessed using subscale 1 of the PoRT scale. PoRT is a validated, self-report measure that assesses confidence in medical research and researchers. Subscale 1 contains 9 items, with response options for each item ranging from 1 (strongly disagree) to 5 (strongly agree); thus the subscale ranges from 9 to 45. Higher scores indicate higher confidence.
Immediately before the co-creation process and immediately following the co-creation process, up to 1 hour
Secondary Outcomes (6)
Perceived appropriateness of research summary - Aim 2
Immediately before the co-creation process and immediately following the co-creation process, up to 1 hour
Institutional confidence - Aim 2
Immediately before the co-creation process and immediately following the co-creation process, up to 1 hour
Research comprehension - Aim 2
Immediately before the co-creation process and immediately following the co-creation process, up to 1 hour
Perceived appropriateness of research summary - Aim 3
Immediately following review of research summary, up to 1 hour
Institutional confidence - Aim 3
Aim 3: Immediately following review of research summary, up to 1 hour
- +1 more secondary outcomes
Study Arms (4)
Standard AI prompt - Aim 3
EXPERIMENTALParticipants receive plain-language research summaries generated using a standardized AI prompt without researcher prompt engineering or community co-design.
Researcher prompt engineering - Aim 3
EXPERIMENTALParticipants receive summaries generated after researchers complete AI prompt-engineering training and develop optimized prompts.
Community co-created AI summaries - Aim 3
EXPERIMENTALParticipants receive summaries developed through an iterative community-researcher co-creation process following AI training and structured co-design sessions.
Co-creation cohort - Aim 2
EXPERIMENTALParticipants will be divided into three groups, each assigned 1-2 research summaries, and will engage in structured co-creation sessions. The goals of will be to: 1) define readability and appropriateness, 2) review AI-generated drafts produced by the summary engine, and 3) provide feedback to refine prompts and outputs. Several iteration cycles will be conducted as needed, with documentation of any changes and the rationale for making decisions. In this way the team will develop a modular AI "summary engine" that transforms research products (e.g., manuscripts) into draft community-facing materials using co-created prompts and templates. Co-creation will be conducted during one or two facilitated sessions. Each session will include structured review of drafts, guided discussion, and documented decisions regarding readability, transparency, visuals or graphics, etc. Iteration cycles will continue until pre-specified stopping criteria are met.
Interventions
Participants review AI-generated summaries refined through iterative collaboration between researchers and community members using community-engaged co-design principles.
Participants review AI-generated summaries generated after researchers complete AI prompt-engineering training and develop optimized prompts.
Participants review plain-language research summaries generated using a standardized AI prompt without researcher prompt engineering or community co-design.
The co-designed summaries which result from this process will become one of the three intervention conditions evaluated in Aim 3.
Eligibility Criteria
You may qualify if:
- English-speaking individuals at least 18 years of age
You may not qualify if:
- Individuals unable to provide informed consent
- Participants who have had formal training in AI prompt engineering
- The eligibility criteria are common to both Aims 2 and 3.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
Related Publications (6)
Shoemaker SJ, Wolf MS, Brach C. Development of the Patient Education Materials Assessment Tool (PEMAT): a new measure of understandability and actionability for print and audiovisual patient information. Patient Educ Couns. 2014 Sep;96(3):395-403. doi: 10.1016/j.pec.2014.05.027. Epub 2014 Jun 12.
PMID: 24973195BACKGROUNDSnyder HR, Miyake A, Hankin BL. Advancing understanding of executive function impairments and psychopathology: bridging the gap between clinical and cognitive approaches. Front Psychol. 2015 Mar 26;6:328. doi: 10.3389/fpsyg.2015.00328. eCollection 2015.
PMID: 25859234BACKGROUNDMarafino BJ, Dudley RA, Shah NH, Chen JH. Accurate and interpretable intensive care risk adjustment for fused clinical data with generalized additive models. AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:166-175. eCollection 2018.
PMID: 29888065BACKGROUNDO'Connor MA, Erasmus JH, Randall S, Archer J, Lewis TB, Brown B, Fredericks M, Groenier S, Iwayama N, Ahrens C, Garrison W, Wangari S, Guerriero KA, Fuller DH. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques. Front Immunol. 2021 Dec 21;12:800723. doi: 10.3389/fimmu.2021.800723. eCollection 2021.
PMID: 34992610BACKGROUNDKreuter MW, Wray RJ. Tailored and targeted health communication: strategies for enhancing information relevance. Am J Health Behav. 2003 Nov-Dec;27 Suppl 3:S227-32. doi: 10.5993/ajhb.27.1.s3.6.
PMID: 14672383BACKGROUNDHolzer JK, Ellis L, Merritt MW. Why we need community engagement in medical research. J Investig Med. 2014 Aug;62(6):851-5. doi: 10.1097/JIM.0000000000000097.
PMID: 24979468BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Kahn, MD, MPH
Albert Einstein College of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Aim 2: N/A Aim 3: Participants are blinded to how the research summaries were developed. The summaries are presented in identical formats without identifying the development method. Study personnel performing the primary analyses remain blinded to treatment assignment until completion of the primary analyses.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2026
First Posted
August 27, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
August 27, 2026
Record last verified: 2026-08